Eledon Pharma Analyst Ratings
H.C. Wainwright Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $16
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Eledon Pharmaceuticals (ELDN)
Ladenburg Thalmann Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Cuts Target Price to $20.5
LifeSci Capital Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $9
Eledon Pharmaceuticals: Strong Financials and Promising Clinical Developments Justify Buy Rating
Noble Financial Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $10
Noble Financial Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $10
Leerink Partners Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating
LifeSci Capital Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $9
Noble Financial Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $10
LifeSci Capital Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $9
Analysts Are Bullish on These Healthcare Stocks: Eledon Pharmaceuticals (ELDN), Opthea Limited Sponsored ADR (OPT)
Buy Rating Justified by Eledon Pharmaceuticals' Strategic Progress and Growth Potential
Leerink Partners Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $7
LifeSci Capital Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $9
Eledon Pharmaceuticals (ELDN) Receives a Buy From Noble Financial
Noble Financial Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $10
Eledon Pharma Analyst Ratings
Eledon Pharma Analyst Ratings